Epidemiology of leukemia in children with down syndrome

Pediatric Blood and Cancer

Volumn 44, Issue 1, 2005, Pages 8-12

  Ross, Julie A ^a,c   Spector, Logan G ^a   Robison, Leslie L ^a   Olshan, Andrew F ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b IL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Down syndrome; Epidemiology; Leukemia; Risk factors

Indexed keywords

TRANSCRIPTION FACTOR GATA 1;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; B LYMPHOCYTE; BIRTH ORDER; BIRTH WEIGHT; CANCER RISK; CELL COMMUNICATION; CHILD; DOWN SYNDROME; ECHOCARDIOGRAPHY; ENVIRONMENTAL EXPOSURE; FETUS WASTAGE; GENE MUTATION; GENE TRANSLOCATION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFECTION RISK; KARYOTYPING; LEUKEMIA; LEUKOCYTE COUNT; MATERNAL AGE; MORTALITY; MYELOPROLIFERATIVE DISORDER; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOGRAPHY; REVIEW; RISK FACTOR; SCREENING TEST; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; ZINC DEFICIENCY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LEUKEMIA; MALE; PREVALENCE; RISK FACTORS;

EID: 10044295164     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20165     Document Type: Review

References (64)

1. Centers for Disease Control. Down syndrome prevalence at birth in the United States, 1983-1990. MMWR 1994;43:617-622.
2. Edmonds LD, James LM. Temporal trends in the birth prevalence of selected congenital malformations in the Birth Defects Monitoring Program/Commission on Professional and Hospital Activities, 1979-1989. Teratology 1993;48:647-649.
3. Hook EB, Cross PK, Jackson L, et al. Maternal age-specific rates of 47,+21, and other cytogenetic abnormalities diagnosed in the first trimester of pregnancy in chorionic villus biopsy specimens: Comparison with rates expected from observations at amniocentesis. Am J Hum Genet 1988;42:797-807.
4. Yoon PW, Freeman SB, Sherman SL, et al. Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: A population-based study. Am J Hum Genet 1996;58:628-633.
5. Korenberg JR, Kawashima H, Pulst SM, et al. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am J Hum Genet 1990;47:236-246.
6. Janerich DT, Bracken MB. Epidemiology of trisomy 21: A review and theoretical analysis. J Chronic Dis 1986;39:1079-1093.
7. Wolff DJ, Schwartz S. The effect of Robertsonian translocation on recombination on chromosome 21. Hum Mol Genet 1993;2:693-699.
8. Shaffer LG, McCaskill C, Haller V, et al. Further characterization of 19 cases of rea(21q21q) and delineation as isochromosomes or Robertsonian translocations in Down syndrome. Am J Med Genet 1993;47:1218-1222.
9. Hook EB, Cross PK, Schreinemachers DM. Chromosomal abnormality rates at amniocentesis and in live-born infants. Jama 1983;249:2034-2038.
10. Benn PA. Advances in prenatal screening for Down syndrome: I. General principles and second trimester testing. Clin Chim Acta 2002;323:1-16.
11. Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 2002;9:2-6.
12. McIntosh GC, Olshan AF, Baird PA. Paternal age and the risk of birth defects in offspring. Epidemiology 1995;6:282-288.
13. Kline J, Levin B, Stein Z, et al. Cigarette smoking and trisomy 21 at amniocentesis. Genet Epidemiol 1993;10:35-42.
14. Khoury MJ, Flanders WD, James LM, et al. Human teratogens, prenatal mortality, and selection bias. Am J Epidemiol 1989;130:361-370.
15. Rothman KJ. Spermicide use and Down's syndrome. Am J Public Health 1982;72:399-401.
16. Warburton D, Neugut RH, Lustenberger A, et al. Lack of association between spermicide use and trisomy. N Engl J Med 1987;317:478-482.
17. Strobino B, Kline J, Lai A, et al. Vaginal spermicides and spontaneous abortion of known karyotype. Am J Epidemiol 1986;123:431-443.
18. Polednak AP, Janerich DT. Uses of available record systems in epidemiologic studies of reproductive toxicology. Am J Ind Med 1983;4:329-348.
19. Olshan AF, Baird PA, Teschke K. Paternal occupational exposures and the risk of Down syndrome. Am J Hum Genet 1989;44:646-651.
20. Schnitzer PG, Olshan AF, Erickson JD. Paternal occupation and risk of birth defects in offspring. Epidemiology 1995;6:577-583.
21. Silverman J, Kline J, Hutzler M, et al. Maternal employment and the chromosomal characteristics of spontaneously aborted conceptions. J Occup Med 1985;27:427-438.
22. Matte TD, Mulinare J, Erickson JD. Case-control study of congenital defects and parental employment in health care. Am J Ind Med 1993;24:11-23.
23. McDonald AD, McDonald JC, Armstrong B, et al. Congenital defects and work in pregnancy. Br J Ind Med 1988;45:581-588.
24. Boue J, Bou A, Lazar P. Retrospective and prospective epidemiological studies of 1,500 karyotyped spontaneous human abortions. Teratology 1975;12:11-26.
25. Strigini P, Pierluigi M, Forni GL, et al. Effect of X-rays on chromosome 21 non-disjunction. Am J Med Genet 1990;7:155-159.
26. Alberman E, Polani PE, Roberts JA, et al. Parental exposure to X-irradiation and Down's syndrome. Ann Hum Genet 1972;36:195-208.
27. Fialkow PJ. Thyroid antibodies, Down's syndrome, and maternal age. Nature 1967;214:1253-1254.
28. Fialkow PJ, Hecht F, Uchida IA, et al. Increased frequency of thyroid autoantibodies in mothers of patients with Down's syndrome. Lancet 1965;2:868-870.
29. Cuckle H, Wald N, Stone R, et al. Maternal serum thyroid antibodies in early pregnancy and fetal Down's syndrome. Prenat Diagn 1988;8:439-445.
30. Khoury MJ, Becerra JE, d'Almada PJ. Maternal thyroid disease and risk of birth defects in offspring: A population-based case-control study. Paediatr Perinat Epidemiol 1989;3:402-420.
31. Brewster HF, Cannon HE. Acute lymphatic leukemia: Report of a case in eleventh month mongolian idiot. New Orleans Med Surg J 1930;82:872-873.
32. Satge D, Sommelet D, Geneix A, et al. A tumor profile in Down syndrome. Am J Med Genet 1998;78:207-216.
33. Robison LL. Down syndrome and leukemia. Leukemia 1992;1 5-7.
34. Zipursky A, Peeters M, Poon A. Megakaryoblastic leukemia and Down's syndrome: A review. Pediatr Hematol Oncol 1987;4:211-230.
35. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: A population-based study. Lancet 2002;359:1019-1025.
36. Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 2000;355:165-169.
37. Ross JA, Davies SM, Potter JD, et al. Epidemiology of childhood leukemia, with a focus on infants. Epidemiol Rev 1994;16:243-272.
38. Hayes A, Batshaw ML. Down syndrome. Pediatr Clin North Am 1993;40:523-535.
39. Adams MM, Erickson JD, Layde PM, et al. Down's syndrome. Recent trends in the United States. Jama 1981;246:758-760.
40. Cuadrado E, Barrena MJ. Immune dysfunction in Down's syndrome: Primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol 1996;78:209-214.
41. Novo E, Garcia MI, Lavergne J. Non-specific immunity in Down syndrome: A study of chemotaxis, phagocytosis, oxidative metabolism, and cell surface marker expression of polymorphonuclear cells. Am J Med Genet 1993;46:384-491.
42. Roizen NJ, Amarose AP. Hematologic abnormalities in children with Down syndrome. Am J Med Genet 1993;46:510-512.
43. Lockitch G, Singh VK, Puterman ML, et al. Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home. Pediatr Res 1987;22:536-540.
44. Greaves MF. Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia 1988;2:120-125.
45. Greaves MF, Pegram SM, Chan LC. Collaborative group study of the epidemiology of acute lymphoblastic leukaemia subtypes: Background and first report. Leuk Res 1985;9:715-733.
46. Greaves MF, Maia AT, Wiemels JL, et al. Leukemia in twins: Lessons in natural history. Blood 2003;102:2321-2333.
47. Greaves MF, Alexander FE. An infectious etiology for common acute lymphoblastic leukemia in childhood? Leukemia 1993;7:349-360.
48. Greaves MF. Aetiology of acute leukaemia. Lancet 1997;349:344-349.
49. McKinney PA, Juszczak E, Findlay E, et al. Pre- and perinatal risk factors for childhood leukaemia and other malignancies: A Scottish case control study. Br J Cancer 1999;80:1844-1851.
50. Jourdan-Da Silva N, Perel Y, Mechinaud F, et al. Infectious diseases in the first year of life, perinatal characteristics, and childhood acute leukaemia. Br J Cancer 2004;90:139-145.
51. Schuz J, Kaletsch U, Meinert R, et al. Association of childhood leukaemia with factors related to the immune system. Br J Cancer 1999;80:585-590.
52. van Steensel-Moll HA, Valkenburg HA, van Zanen GE. Childhood leukemia and infectious diseases in the first year of life: A register-based case-control study. Am J Epidemiol 1986;124:590-594.
53. Neglia JP, Linet MS, Shu XO, et al. Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 2000;82:234-240.
54. Chiricolo M, Musa AR, Monti D, et al. Enhanced DNA repair in lymphocytes of Down syndrome patients: The influence of zinc nutritional supplementation. Mutat Res 1993;295:105-111.
55. Licastro F, Mocchegiani E, Zannotti M, et al. Zinc affects the metabolism of thyroid hormones in children with Down's syndrome: Normalization of thyroid stimulating hormone and of reversal triiodothyronine plasmic levels by dietary zinc supplementation. Int J Neurosci 1992;65:259-268.
56. Licastro F, Chiricolo M, Mocchegiani E, et al. Oral zinc supplementation in Down's syndrome subjects decreased infections and normalized some humoral and cellular immune parameters. J Intellect Disabil Res 1994;38:149-162.
57. Napolitano G, Palka G, Lio S, et al. Is zinc deficiency a cause of subclinical hypothyroidism in Down syndrome? Ann Genet 1990;33:9-15.
58. Colombo ML, Givrardo E, Ricci BM, et al. [Blood zinc in patients with Down's syndrome and its relations with their immune status]. Minerva Pediatr 1989;41:71-75.
59. Colombo ML, Girardo E, Incarbone E, et al. [Vitamin C in children with trisomy 21]. Minerva Pediatr 1989;41:189-192.
60. Cartlidge PH, Curnock DA. Specific malabsorption of vitamin B12 in Down's syndrome. Arch Dis Child 1986;61:514-515.
61. Purice M, Maximilian C, Dumitriu I, et al. Zinc and copper in plasma and erythrocytes of Down's syndrome children. Endocrinologie 1988;26:113-117.
62. Gurbuxani S, Vyas P, Crispino JD. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood 2004;103:399-406.
63. Zipursky A, Poon A, Doyle J. Leukemia in Down syndrome: A review. Pediatr Hematol Oncol 1992;9:139-149.
64. Ross JA, Potter JD, Reaman GH, et al. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): A report from the Children's Cancer Group. Cancer Causes Control 1996;7:581-590.